← Leaderboards
Kabre Heck
Auburn University At Auburn
$54,852
Attributed
$54,852
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $38.6K · FY2023–24$50K$37.5K$25K$12.5K$0
'23
'24
Funding mix
By agency
NIH$54,852 · 1
By mechanism
F31$54,852 · 1
Top collaborators
No co-investigators on record.
Most similar at Auburn University At Auburn
Same institution · by research overlap
- Rashad Karimov$1,496,033
- Angela Isabel Calderon$952,701
- Benson Tokunbo Akingbemi$684,140
Others in their field
Other Rising Stars on “Adverse Event”
- Lauren Miller · Technical Resources International, Inc.$31,120,905
- Cynthia M Visness · Rho Federal Systems Division, Inc.$14,006,776
- Cathie Snyder · Rho Federal Systems Division, Inc.$13,688,224
- Jinsy Andrews · Columbia University Health Sciences$11,474,975
- Benjamin M Greenberg · Ut Southwestern Medical Center$11,474,975
- Eric Anderson · Columbia University Health Sciences$11,474,975
Research focus
Adverse EventAntineoplastic AgentsAssay DevelopmentBaculovirusesBioactive Natural ProductsBiologicalBlood VesselsBotanical Dietary SupplementsBotanicalsCancer DiagnosisCancer PatientCancer TherapyCardiotoxicityCardiovascular Risk FactorCardiovascular SystemCareerCause Of DeathCellsCessation Of LifeChemical FingerprintingChemotherapeutic AgentChemotherapyClinically RelevantCollaborations
Grant awards (2)
Evaluation of Euterpe oleracea Mart. (açaÃ) for inhibition of UGTs as a mechanism of botanical-drug interactions involving anticancer drugs$16,299
F31 · FY2024 · AT · contact PI
Evaluation of Euterpe oleracea Mart. (açaÃ) for inhibition of UGTs as a mechanism of botanical-drug interactions involving anticancer drugs$38,553
F31 · FY2023 · AT · contact PI